{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:39:05Z","timestamp":1773203945132,"version":"3.50.1"},"reference-count":217,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ayurveda and Integrative Medicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jaim.2022.100545","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T13:26:05Z","timestamp":1654003565000},"page":"100545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations"],"prefix":"10.1016","volume":"13","author":[{"given":"E.N.T.","family":"Vikram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ilavarasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kamaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaim.2022.100545_bib1","series-title":"What is cancer?","author":"Institute","year":"2021"},{"key":"10.1016\/j.jaim.2022.100545_bib2","doi-asserted-by":"crossref","unstructured":"Prashant M, Krishnan S, Meesha C, Priyanka D, Kondalli L S, Stephen S, et\u00a0al. Cancer statistics, 2020: report from National Cancer Registry Programme, India. JCO Global Oncol 6:1063\u20131075.","DOI":"10.1200\/GO.20.00122"},{"key":"10.1016\/j.jaim.2022.100545_bib3","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(14)70115-9","article-title":"The growing burden of cancer in India: epidemiology and social context","volume":"15","author":"Mallath","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaim.2022.100545_bib4","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Hyuna","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaim.2022.100545_bib5","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaim.2022.100545_bib6","series-title":"The ayurveda encyclopedia","first-page":"3","year":"2005"},{"key":"10.1016\/j.jaim.2022.100545_bib7","series-title":"Schedule E (1), Rule 161(2)","first-page":"317","year":"1940"},{"key":"10.1016\/j.jaim.2022.100545_bib8","series-title":"Schedule E (1), Rule 161(2)","first-page":"300","year":"1945"},{"key":"10.1016\/j.jaim.2022.100545_bib9","first-page":"3","article-title":"Evaluation of toxicity of \u2018Vatsanabha\u2019 (Aconitum ferox, Ranunculaceae) before and after Shodhana","volume":"5","author":"Deore","year":"2013","journal-title":"J\u00a0Young Pharm"},{"key":"10.1016\/j.jaim.2022.100545_bib10","first-page":"233","article-title":"A\u00a0review of Aconite (Vatsanabha) usage in Ayurvedic formulations: traditional views and their inferences","volume":"1","author":"Rastogi","year":"2011","journal-title":"Spat DD \u2013 Peer Rev J Complement Med Drug Discov"},{"key":"10.1016\/j.jaim.2022.100545_bib11","series-title":"Medicinal plants: chemistry, biology and omics","first-page":"217","author":"Hao","year":"2015"},{"key":"10.1016\/j.jaim.2022.100545_bib12","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1021\/jm501180v","article-title":"Progress toward the development of noscapine and derivatives as anticancer agents","volume":"58","author":"DeBono","year":"2015","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jaim.2022.100545_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3109\/15376516.2015.1045656","article-title":"Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and Papaverine on breast cancer stem cells","volume":"25","author":"Sajadian","year":"2015","journal-title":"Toxicol Mech Methods"},{"issue":"3","key":"10.1016\/j.jaim.2022.100545_bib14","first-page":"349","article-title":"Anticancer activity of papaver somniferum L","volume":"3","author":"Guler","year":"2016","journal-title":"J\u00a0Turk Chem Soc \u2013 Sec A"},{"issue":"5","key":"10.1016\/j.jaim.2022.100545_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216358","article-title":"Anticancer effects of a non-narcotic opium alkaloid medicine, Papaverine, in human glioblastoma cells","volume":"14","author":"Inada","year":"2019","journal-title":"PLoS One"},{"issue":"6089","key":"10.1016\/j.jaim.2022.100545_bib16","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1220757","article-title":"A\u00a0papaver somniferum 10-gene cluster for synthesis of the anticancer alkaloid noscapine","volume":"336","author":"Winzer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jaim.2022.100545_bib17","series-title":"Manoa campus plants","author":"Carr","year":"2003"},{"key":"10.1016\/j.jaim.2022.100545_bib18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S1995-7645(11)60194-6","article-title":"Evaluation of antitumour activity of Calotropis gigantea L. root bark against Ehrlich ascites carcinoma in Swiss albino mice","author":"Habib","year":"2011","journal-title":"Asian Pac J Trop Med"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib19","first-page":"803","article-title":"Cytotoxic cardenolide and sterols from Calotropis gigantea","volume":"6","author":"Jacinto","year":"2011","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.jaim.2022.100545_bib20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2478\/v10007-012-0035-9","article-title":"Antitumour evaluation of di-(2-ethylhexyl) phthalate (DEHP) isolated from Calotropis gigantea L. flower","volume":"62","author":"Habib","year":"2012","journal-title":"Acta Pharm"},{"issue":"7","key":"10.1016\/j.jaim.2022.100545_bib21","first-page":"197","article-title":"Ethyl acetate fraction of Calotropis gigantea roots induce apoptosis through increased G2\/M and increased expression of caspase-8 in colon cancer WiDr cell line","volume":"7","author":"Mutiah","year":"2017","journal-title":"J\u00a0Appl Pharmaceut Sci"},{"key":"10.1016\/j.jaim.2022.100545_bib22","unstructured":"Mutiah R, Widyawaruyanti A, Sukardiman S, Calotroposid A: A glycosides terpenoids from Calotropis gigantea induces apoptosis of colon cancer WiDr cells through cell cycle arrest G2\/M and caspase 8 expression, Asian Pac J Cancer Prev APJCP, 19 (6), 1457-1464."},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib23","first-page":"51","article-title":"Calotropis gigantea leaf extract increases the efficacy of 5-fluorouracil and decreases the efficacy of doxorubicin in widr colon cancer cell culture","volume":"8","author":"Mutiah","year":"2018","journal-title":"J\u00a0Appl Pharmaceut Sci"},{"issue":"3","key":"10.1016\/j.jaim.2022.100545_bib24","first-page":"167","article-title":"The effect of Calotropis gigantea leaves extract on fibrosarcoma growth and caspase 3 expression","volume":"8","author":"Mutiah","year":"2016","journal-title":"Int J Pharmaceut Chem Res"},{"issue":"9","key":"10.1016\/j.jaim.2022.100545_bib25","first-page":"3918","article-title":"Antiproliferative effect of Calotropis gigantea (L.) R. BR. on breast cancer cells MCF-7","volume":"5","author":"Bhat","year":"2014","journal-title":"Int J Pharmaceut Sci Res"},{"key":"10.1016\/j.jaim.2022.100545_bib26","first-page":"131","article-title":"Phytochemical screening and evaluation of cytotoxic activity of Calotropis gigantea leaf extract on MCF7, HeLa, and A549 cancer cell lines","volume":"10","author":"Damodaran","year":"2019","journal-title":"J\u00a0Nat Sci Biol Med"},{"key":"10.1016\/j.jaim.2022.100545_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1099-1573(199905)13:3<183::AID-PTR420>3.0.CO;2-5","article-title":"Anticancer potency of the milk extract of Semecarpus anacardium Linn. Nuts against aflatoxin B1 mediated hepatocellular carcinoma bearing wistar rats with reference to tumour marker enzymes","volume":"13","author":"Premalatha","year":"1999","journal-title":"Phytother Res"},{"key":"10.1016\/j.jaim.2022.100545_bib28","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.cellbi.2007.04.004","article-title":"Apoptotic effect of Semecarpus anacardium nut extract on T47D breast cancer cell line","volume":"31","author":"Mathivadhani","year":"2007","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jaim.2022.100545_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2007.01.013","article-title":"Alteration of DMBA-induced oxidative stress by additive action of a modified indigenous preparation-- Kalpaamruthaa","volume":"167","author":"Arulkumaran","year":"2007","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jaim.2022.100545_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cbi.2008.01.013","article-title":"Restoration of energy metabolism in leukemic mice treated by a siddha drug: Semecarpus anacardium Linn. nut milk extract","volume":"173","author":"Sugapriya","year":"2008","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib31","first-page":"1429","article-title":"Invitro cytotoxicity activity of Semecarpus anacardium extract against Hep2 cell line and Vero cell line","volume":"1","author":"Patel","year":"2009","journal-title":"Int J Pharm Tech Res"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib32","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00425-004-1405-4","article-title":"Investigation on Semecarpus anacardium L a siddha medicine for breast cancer","volume":"220","author":"Sowmyalakshmi","year":"2005","journal-title":"Planta"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib33","first-page":"6","article-title":"Anti-tumour activity of the extract of Semecarpus anacardium L. nuts in experimental tumor models","volume":"18","author":"Chitnis","year":"1980","journal-title":"Indian J Exp Biol"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib34","first-page":"166","article-title":"Cytotoxicity of the acetylated oil of Semecarpus anacardium Linn","volume":"27","author":"Phatak","year":"1983","journal-title":"Indian J Phys Pharm"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib35","first-page":"83","article-title":"Antitumour and pharmacological effects of the oil from Semecarpus anacardium Linn. F.","volume":"27","author":"Indap","year":"1983","journal-title":"Indian J Physiol Pharmacol"},{"issue":"8","key":"10.1016\/j.jaim.2022.100545_bib36","first-page":"447","article-title":"Potentiation of activity of anti-cancer drugs by acetylated oil of Semecarpus anacardium Linn. F. in experimental tumours","volume":"23","author":"Indap","year":"1986","journal-title":"Indian Drugs"},{"issue":"5","key":"10.1016\/j.jaim.2022.100545_bib37","first-page":"301","article-title":"In\u00a0vitro studies on antimutagenecity of water, alcoholic and oil extracts of Semecarpus anacardium","volume":"29","author":"Kothari","year":"1997","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0378-8741(95)01255-C","article-title":"Ayurvedic herbal drugs with possible cytostatic activity","volume":"47","author":"Smit","year":"1995","journal-title":"J\u00a0Ethnopharmacol"},{"issue":"5","key":"10.1016\/j.jaim.2022.100545_bib39","first-page":"491","article-title":"The anticancer activity of Semecarpus anacardium. I.9 KB active pentadecylaccatechols","volume":"41","author":"Hembree","year":"1978","journal-title":"Lloydia"},{"issue":"8","key":"10.1016\/j.jaim.2022.100545_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ptr.1501","article-title":"Cytotoxic effect of root extract of Tiliacora racemosa and oil of Semecarpus anacardium Linn. nut in human tumour cells","volume":"18","author":"Chakraborty","year":"2004","journal-title":"Phytother Res"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib41","first-page":"910","article-title":"Investigation on Semecarpus Lehyam-a siddha medicine for breast cancer","volume":"220","author":"Sowmyalakshmi","year":"2005","journal-title":"Planta Med"},{"key":"10.1016\/j.jaim.2022.100545_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/978-3-319-20825-1_16","article-title":"Endocannabinoids and cancer","volume":"231","author":"Velasco","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci"},{"issue":"Suppl 2","key":"10.1016\/j.jaim.2022.100545_bib44","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.3747\/co.23.3080","article-title":"Anticancer mechanisms of can-nabinoids","volume":"23","author":"Velasco","year":"2016","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib45","doi-asserted-by":"crossref","first-page":"djv077","DOI":"10.1093\/jnci\/djv077","article-title":"Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer","volume":"107","author":"Perez-Gomez","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaim.2022.100545_bib46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1476-4598-9-196","article-title":"Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition","volume":"9","author":"Caffarel","year":"2010","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejca.2008.10.010","article-title":"A\u00a0high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer","volume":"45","author":"Chung","year":"2009","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065798","article-title":"Association between cannabinoid CB1 receptor expression and Akt signalling in prostate cancer","volume":"8","author":"Cipriano","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaim.2022.100545_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pnpbp.2015.05.010","article-title":"The use of canna-binoids as anticancer agents","volume":"64","author":"Velasco","year":"2016","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.jaim.2022.100545_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012275","article-title":"Fatty acid amide hydrolase in prostate cancer: Association with disease severity and outcome, CB1 receptor expression and regulation by IL-4","volume":"5","author":"Thors","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/0008-5472.CAN-07-2785","article-title":"Cannabinoids for cancer treatment: progress and promise","volume":"68","author":"Sarfaraz","year":"2008","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib52","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3892\/or.2015.3746","article-title":"Proapoptotic effect of endocannabinoids in prostate cancer cells","volume":"33","author":"Orellana-Serradell","year":"2015","journal-title":"Oncol Rep"},{"issue":"1\u20133","key":"10.1016\/j.jaim.2022.100545_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2005.04.010","article-title":"Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue","volume":"515","author":"Sanchez","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.jaim.2022.100545_bib54","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.bbamcr.2016.05.007","article-title":"Activation of endogenous TRPV1 fails to induce overstimulation-based cytotoxicity in breast and prostate cancer cells but not in pain-sensing neurons","volume":"1863","author":"Pecze","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1476-5381.2012.02027.x","article-title":"Non-THC cannabinoids inhibit prostate carcinoma growth in\u00a0vitro and in\u00a0vivo: pro-apoptotic effects and underlying mechanisms","volume":"168","author":"De Petrocellis","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/onc.2010.417","article-title":"The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation","volume":"30","author":"Pineiro","year":"2011","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.jaim.2022.100545_bib57","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/hep.27686","article-title":"Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms","volume":"61","author":"Mukhopadhyay","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergencyto.2006.06.014","article-title":"Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma","volume":"171","author":"Xu","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-10-0181","article-title":"Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis","volume":"4","author":"Preet","year":"2011","journal-title":"Cancer Prev Res"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156693","article-title":"Cannabinoid receptors are overexpressed in CLL but of limited potential for therapeutic exploitation","volume":"11","author":"Freund","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib61","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ijc.23114","article-title":"Cannabinoids in pancreatic cancer: correlation with survival and pain","volume":"122","author":"Michalski","year":"2008","journal-title":"Int J Cancer"},{"issue":"15","key":"10.1016\/j.jaim.2022.100545_bib62","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.18632\/oncotarget.2233","article-title":"Cannabinoids as therapeutic agents in cancer: current status and future implications","volume":"5","author":"Chakravarti","year":"2014","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.jaim.2022.100545_bib63","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1158\/0008-5472.CAN-06-0169","article-title":"Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes","volume":"66","author":"Carracedo","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib64","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/0973-1482.106534","article-title":"Cannabinoid receptor 2 is upregulated in melanoma","volume":"8","author":"Zhao","year":"2012","journal-title":"J\u00a0Cancer Res Therapeut"},{"key":"10.1016\/j.jaim.2022.100545_bib65","first-page":"301","article-title":"Critical appraisal of the potential use of cannabinoids in cancer management","volume":"5","author":"Cridge","year":"2013","journal-title":"Cancer Manag Res"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib66","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-03-3720","article-title":"Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE\/ADAM17)-mediated transactivation of the epidermal growth factor receptor","volume":"64","author":"Hart","year":"2004","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.jaim.2022.100545_bib67","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol Cancer Therapeut"},{"issue":"10","key":"10.1016\/j.jaim.2022.100545_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076918","article-title":"Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect","volume":"8","author":"Solinas","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jaim.2022.100545_bib69","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4236\/pp.2014.58091","article-title":"In\u00a0vitro anticancer activity of plant-derived cannabidiol on prostate cancer cell lines","volume":"5","author":"Sharma","year":"2014","journal-title":"Pharmacol Pharm"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/1535-7163.MCT-09-0407","article-title":"Cannabidiol enhances the inhibitory effects of delta9-tetrahy-drocannabinol on human glioblastoma cell proliferation and survival","volume":"9","author":"Marcu","year":"2010","journal-title":"Mol Cancer Therapeut"},{"issue":"7","key":"10.1016\/j.jaim.2022.100545_bib71","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Future Med Chem"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib72","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"\u0394-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response","volume":"174","author":"McKallip","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib73","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4049\/jimmunol.165.1.373","article-title":"\u0394-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway","volume":"165","author":"Zhu","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaim.2022.100545_bib74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharma-codynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jaim.2022.100545_bib75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/SAR.S73586","article-title":"Emerging drugs of abuse: current perspectives on synthetic cannabinoids","volume":"6","author":"Debruyne","year":"2015","journal-title":"Subst Abuse Rehabil"},{"issue":"Pt A","key":"10.1016\/j.jaim.2022.100545_bib76","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.phrs.2016.07.045","article-title":"Pure delta9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in delta9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages","volume":"113","author":"Romano","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaim.2022.100545_bib77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002620000109","article-title":"Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses","volume":"49","author":"Ke","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaim.2022.100545_bib78","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1124\/mol.105.021899","article-title":"Development of a novel nitro-derivative of noscapine for the potential treatment of drug- resistant ovarian cancer and T-cell lymphoma","volume":"69","author":"Aneja","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaim.2022.100545_bib79","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1182\/blood-2005-08-3516","article-title":"Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011","volume":"107","author":"Aneja","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaim.2022.100545_bib80","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1158\/1535-7163.MCT-06-0205","article-title":"Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice","volume":"5","author":"Aneja","year":"2006","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.jaim.2022.100545_bib81","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1158\/0008-5472.CAN-05-2962","article-title":"Rational design of the microtubule-targeting anti-breast cancer drug EM015","volume":"66","author":"Aneja","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaim.2022.100545_bib82","first-page":"4109","article-title":"Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma","volume":"62","author":"Landen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaim.2022.100545_bib83","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/mol.63.4.799","article-title":"Brominated derivatives of noscapine are potent microtubule interfering agents that perturb mitosis and inhibit cell proliferation","volume":"63","author":"Zhou","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaim.2022.100545_bib84","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-04-0360","article-title":"Noscapine Crosses the blood-brain barrier and inhibits glioblastoma growth","volume":"10","author":"Landen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaim.2022.100545_bib85","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1158\/0008-5472.CAN-06-4282","article-title":"P53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells","volume":"67","author":"Aneja","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaim.2022.100545_bib86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00280-008-0720-z","article-title":"Antitumor activity of noscapine in human non-small cell lung cancer xenograft model","volume":"63","author":"Jackson","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaim.2022.100545_bib87","article-title":"Cannabis as an anticancer agent: a review of clinical data and assessment of case reports","author":"Guggisberg","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib88","first-page":"213","article-title":"In-vitro cytotoxic activity of Baliospermum Montanum leaves on cervical cancer- Hela cell lines and chemical characterization by GCMS","volume":"9","author":"Seethalaxmi","year":"2018","journal-title":"Int J Pharm Bio Sci"},{"key":"10.1016\/j.jaim.2022.100545_bib89","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0028-1097367","article-title":"Potential anticancer agents VIII. Constituents of Baliospermum montanum (Euphorbiaceae)","volume":"33","author":"Ogura","year":"1978","journal-title":"Planta Med"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib90","first-page":"173","article-title":"In-vitro anticancer activity of Baliospermum montanum on T-cell leukemia- Jurkat cell line and Human Breast cancer MCF-7","volume":"5","author":"Seethalakshmi","year":"2018","journal-title":"IAETSD J Adv Sci Appl Sci"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib91","first-page":"283","article-title":"Microwave irradiation assisted synthesis of silver nanoparticle using leaf extract of Baliospermum montanum and evaluation of its antimicrobial, anticancer potential activity","volume":"5","author":"Renugadevi","year":"2012","journal-title":"Asian J Pharmaceut Clin Res"},{"key":"10.1016\/j.jaim.2022.100545_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12906-019-2449-0","article-title":"Potential in\u00a0vitro anti-allergic, anti-inflammatory and cytotoxic activities of ethanolic extract of Baliospermum montanum root, its major components and a validated HPLC method","volume":"19","author":"Pipatrattanaseree","year":"2019","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.jaim.2022.100545_bib93","first-page":"63","article-title":"In\u00a0vitro antioxidant and cytotoxicity activity of Bacopa monnieri and Baliospermum","volume":"4","author":"Nandagaon","year":"2013","journal-title":"Montanum Muell Arg"},{"key":"10.1016\/j.jaim.2022.100545_bib94","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.biopha.2015.02.016","article-title":"Effect of Baliospermum montanum nanomedicine apoptosis induction and antimigration of prostate cancer cells","volume":"71","author":"Cherian","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaim.2022.100545_bib95","first-page":"15","article-title":"Alakaloid content of the leaves of three Nigerian Datura species Nig","volume":"6","author":"Nuhu","year":"2002","journal-title":"J\u00a0Nat Prod Med"},{"key":"10.1016\/j.jaim.2022.100545_bib96","series-title":"Medicinal plants of Bangladesh","first-page":"794","author":"Yusuf","year":"2009"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib97","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cbdv.200690021","article-title":"I, and J: three new withanolide glycosides from Datura metel L","volume":"3","author":"Ma","year":"2006","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.jaim.2022.100545_bib98","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/np070096b","article-title":"Cytotoxic withanolides from the flowers of Datura metel","volume":"70","author":"Pan","year":"2007","journal-title":"J\u00a0Nat Prod"},{"issue":"Suppl 1","key":"10.1016\/j.jaim.2022.100545_bib99","first-page":"181","article-title":"Anti-cancer activity of Datura metel on MCF-7 cell line","volume":"7","author":"Nazeema Banu","year":"2014","journal-title":"Asian J Pharmaceut Clin Res"},{"issue":"16","key":"10.1016\/j.jaim.2022.100545_bib100","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.phytochem.2011.07.009","article-title":"Cytotoxic activity of withanolides isolated from Tunisian Datura metel L","volume":"72","author":"Bellila","year":"2011","journal-title":"Phytochemistry"},{"key":"10.1016\/j.jaim.2022.100545_bib101","article-title":"Chemical composition and cytotoxicity of the essential oil from different parts of Datura metel L","author":"Xue","year":"2015","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.jaim.2022.100545_bib102","first-page":"293","article-title":"In\u00a0vitro cytotoxicity and apoptosis induction in human cancer cells by culture extract of an endophytic Fusarium solani strain isolated from Datura metel L","volume":"5","author":"Kuriakose","year":"2014","journal-title":"Pharm Anal Acta"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib103","first-page":"37","article-title":"Abrus precatorius Linn (Fabaceae): phytochemistry, ethnomedicinal uses, ethnopharmacology and pharmacological activities","volume":"1","author":"Okhale","year":"2016","journal-title":"Int J Pharmaceut Sci Res"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib104","first-page":"336","article-title":"Pharmacological activities of Abrus precatorius Linn. - a review","volume":"2","author":"Chaudhari","year":"2012","journal-title":"Int J Ayurvedic Herbal Med"},{"key":"10.1016\/j.jaim.2022.100545_bib105","first-page":"724","article-title":"Bhaisajya Ratnavali of Govinda Dasji Bhisagratna; Volume II, chapter 44, Verse 77, 80-81, Varanasi","volume":"719","author":"Lochan","year":"2009","journal-title":"Chaukhamba Sanskrit Sansthan"},{"issue":"8","key":"10.1016\/j.jaim.2022.100545_bib106","first-page":"29","article-title":"Induction of caspase-3 dependent apoptosis, cell cycle arrest and cytotoxicity in breast cancer cells by Abrus precatorius","volume":"10","author":"Sofi","year":"2018","journal-title":"Int J Pharm Pharmaceut Sci"},{"key":"10.1016\/j.jaim.2022.100545_bib107","first-page":"1447","article-title":"Effect of Abrus precatorius L. on experimental tumors","volume":"29","author":"Subba","year":"1969","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaim.2022.100545_bib108","first-page":"101","article-title":"Angiospermous seeds of medicinal importance","volume":"25","author":"Siddiqi","year":"2001","journal-title":"J\u00a0Econ Taxon Bot"},{"key":"10.1016\/j.jaim.2022.100545_bib109","first-page":"69","article-title":"Antitumour effect of abrin on transplanted tumours in mice","volume":"46","author":"Ramnath","year":"2002","journal-title":"Indian J Physiol Pharmacol"},{"issue":"22","key":"10.1016\/j.jaim.2022.100545_bib110","first-page":"3984","article-title":"Studies on cytotoxicity and antitumor screening of red and white forms of Abrus precatorius L","volume":"7","author":"Sivakumar","year":"2008","journal-title":"Afr J Biotechnol"},{"key":"10.1016\/j.jaim.2022.100545_bib111","series-title":"Phytochemical methods","author":"Harborne","year":"1984"},{"key":"10.1016\/j.jaim.2022.100545_bib112","volume":"vol. 1","author":"Manjunath","year":"1948"},{"key":"10.1016\/j.jaim.2022.100545_bib113","first-page":"146","article-title":"A\u00a0HPTLC study for assessment of sodhana effect on alkaloids of gunja (Abrus precatorius)","volume":"14","author":"Gautam","year":"2001","journal-title":"Aryavaidyan"},{"key":"10.1016\/j.jaim.2022.100545_bib114","series-title":"Pharmacognostical, phytochemical and pharmacological studies on Abrus precatorius L","author":"Sivakumar","year":"2002"},{"key":"10.1016\/j.jaim.2022.100545_bib115","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/aps.2014.15","article-title":"Abrus agglutinin suppresses human hepatocellular carcinoma in\u00a0vitro and in\u00a0vivo by inducing caspase mediated cell death","volume":"35","author":"Subhadip","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jaim.2022.100545_bib116","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6882-13-53","article-title":"Antioxidant and antiproliferative activities of Abrus precatorius leaf extracts - an in\u00a0vitro study","volume":"13","author":"Gul","year":"2013","journal-title":"BMC Compl Alternative Med"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib117","first-page":"307","article-title":"Anti proliferative and apoptosis inducing effects of Abrus precatorius against Human monocytic leukaemia (THP-1) Cell line","volume":"80","author":"Gul","year":"2018","journal-title":"Indian J Pharmaceut Sci"},{"key":"10.1016\/j.jaim.2022.100545_bib118","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40816-019-0143-x","article-title":"Anti-proliferative and immunomodulatory activities of fractions from methanol root extract of Abrus precatorius L","volume":"5","author":"Okoro","year":"2019","journal-title":"Clinical Phytoscience"},{"key":"10.1016\/j.jaim.2022.100545_bib119","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13205-018-1395-8","article-title":"Chemopreventive and anti-breast cancer activity of compounds isolated from leaves of Abrus precatorius L.","volume":"8","author":"Sofi","year":"2018","journal-title":"3 Biotech"},{"issue":"5","key":"10.1016\/j.jaim.2022.100545_bib120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S2222-1808(15)61050-7","article-title":"GC-MS analysis and cytotoxic activity of essential oils from the leaves of Abrus precatorius L. Gaertn","volume":"6","author":"Oladimeji","year":"2016","journal-title":"Asian Pac J Trop Dis"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib121","first-page":"262","article-title":"Phytochemical analysis, in\u00a0vitro anticancer activity and HPTLC fingerprint profile of seeds of Abrus precatorius L","volume":"33","author":"Patil","year":"2015","journal-title":"Int J Pharmaceut Sci Rev Res"},{"issue":"8","key":"10.1016\/j.jaim.2022.100545_bib122","first-page":"112","article-title":"Phytochemical analysis and in\u00a0vitro anticancer effect of aqueous extract of Abrus precatorius Linn","volume":"7","author":"L\u00e9bri","year":"2015","journal-title":"Der Pharma Chem"},{"key":"10.1016\/j.jaim.2022.100545_bib123","unstructured":"Khalifa N S, El-Hallouty S M, Barakat H S, Salim D M, In\u00a0vitro cytotoxic and antioxidant activities of some plant extracts on different human cancer cell lines, 2013, Egypt. J Exp Biol (Bot), 9(1): 137 \u2013 144."},{"key":"10.1016\/j.jaim.2022.100545_bib124","series-title":"Flora of China","first-page":"133","author":"Qiu","year":"1996"},{"key":"10.1016\/j.jaim.2022.100545_bib125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jep.2008.01.023","article-title":"Effects of essential oil from Croton tiglium L. on intestinal transit in mice","volume":"117","author":"Wang","year":"2008","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.jaim.2022.100545_bib126","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1055\/s-2006-962595","volume":"54","author":"Glaser","year":"1988","journal-title":"Planta Med"},{"key":"10.1016\/j.jaim.2022.100545_bib127","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1248\/cpb.47.1346","volume":"47","author":"El-Mekkawy","year":"1999","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.jaim.2022.100545_bib128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0031-9422(99)00556-7","volume":"53","author":"El-Mekkawy","year":"2000","journal-title":"Phytochemistry"},{"key":"10.1016\/j.jaim.2022.100545_bib129","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1073\/pnas.95.9.5357","article-title":"Effect of intravenous infusions 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: preliminary studies on therapeutic efficacy and toxicity","volume":"95","author":"Han","year":"1998","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.jaim.2022.100545_bib130","first-page":"177","article-title":"Cytotoxic effects of extract (cp-2) from the mixture of Coptis and Croton tiglium L. of the various tumor cell lines","volume":"58","author":"Kim","year":"1993","journal-title":"Korean Cent J Med"},{"key":"10.1016\/j.jaim.2022.100545_bib131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02974234","article-title":"Isolation of isoguanosine from Croton tiglium and its antitumor activity","volume":"17","author":"Kim","year":"1994","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jaim.2022.100545_bib132","first-page":"425","article-title":"Structural activity relations and cross resistance observed on evaluation of a series of purine analogs against experimental Neoplasms","volume":"19","author":"Skipper","year":"1959","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib133","doi-asserted-by":"crossref","first-page":"S1532","DOI":"10.1016\/j.jtho.2016.11.2120","article-title":"Croton tiglium extract induces the apoptosis in human lung cancer A549 cells","volume":"12","author":"Li","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.jaim.2022.100545_bib134","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1073\/pnas.76.3.1293","article-title":"Induction of terminal differentiation in human promyelocytic leukemia cells by tumor promoting agents","volume":"76","author":"Huberman","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.jaim.2022.100545_bib135","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1073\/pnas.76.10.5158","article-title":"Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion","volume":"76","author":"Lotem","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4395","key":"10.1016\/j.jaim.2022.100545_bib136","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.286421","article-title":"Induction of differentiation in human promyelocytic leukemia cells by tumor promoters","volume":"204","author":"Rovera","year":"1979","journal-title":"Science (Wash DC)"},{"key":"10.1016\/j.jaim.2022.100545_bib137","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/284069a0","article-title":"Terminal differentiation in human promyelocytic leukemic cells in the absence of DNA synthesis","volume":"284","author":"Rovera","year":"1980","journal-title":"Nature (Lond)"},{"issue":"10","key":"10.1016\/j.jaim.2022.100545_bib138","first-page":"2260","article-title":"12-O-tetradecanoylphorbol-13-acetate induced apoptosis in LNCaP cells is mediated through ceramide synthase","volume":"58","author":"Garzotto","year":"1998","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib139","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jcp.1041450122","article-title":"Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells","volume":"145","author":"Guilbaud","year":"1990","journal-title":"J\u00a0Cell Physiol"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.2910560215","article-title":"Growth inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13 acetate","volume":"56","author":"Arita","year":"1994","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib141","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/ijc.2910450626","article-title":"Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester","volume":"45","author":"Salge","year":"1990","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib142","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/ijc.2910450626","article-title":"Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester","volume":"45","author":"Salge","year":"1990","journal-title":"Int J Cance"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib143","first-page":"419","article-title":"Persistent membrane translocation of protein kinase C alpha during 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate human","volume":"7","author":"Powell","year":"1996","journal-title":"Cell Growth Differ"},{"issue":"11","key":"10.1016\/j.jaim.2022.100545_bib144","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1074\/jbc.275.11.7574","article-title":"Involvement of protein kinase C delta (PKC delta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKC delta","volume":"275","author":"Fujii","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"4A","key":"10.1016\/j.jaim.2022.100545_bib145","first-page":"1843","article-title":"Growth control of human prostate cancer cells by the phorbol ester TPA: possible involvement of protein kinases","volume":"16","author":"Konno","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jaim.2022.100545_bib146","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1158\/0008-5472.CAN-03-2848","article-title":"Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans-retinoic acid on the growth of LNCaP prostate tumors in immunodeficient mice","volume":"64","author":"Zheng","year":"2004","journal-title":"Cancer Res"},{"issue":"3 part 1","key":"10.1016\/j.jaim.2022.100545_bib147","first-page":"800","article-title":"Tumor necrosis factor-\u03b1 represses androgen sensitivity in the LNCaP prostate cancer cell line","volume":"164","author":"Mizokami","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jaim.2022.100545_bib148","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/blood-2002-09-2725","article-title":"Synergy between all transretinoic acid and tumor necrosis factor pathways in acute leukemia cells","volume":"102","author":"Witcher","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaim.2022.100545_bib149","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00001756-200002070-00033","article-title":"Effects of retinoic acid and tumor necrosis factor-\u03b1 on GL-15 glioblastoma cells","volume":"11","author":"Chambaut-Guerin","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.jaim.2022.100545_bib150","unstructured":"Changyou Li, Xiao Wu, Rongli Sun, Peng Zhao, Fengjuan Liu, Chunling Zhang, Croton tiglium extract induces apoptosis via Bax\/Bcl-2 pathways in human lung cancer A549 cells, Asian Pac J Cancer Prev APJCP, Vol 17, 4893-4898."},{"issue":"5","key":"10.1016\/j.jaim.2022.100545_bib151","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/np300832n","article-title":"Cytotoxic phorbol esters of Croton tiglium","volume":"76","author":"Zhang","year":"2013","journal-title":"J\u00a0Nat Prod"},{"key":"10.1016\/j.jaim.2022.100545_bib152","doi-asserted-by":"crossref","unstructured":"Junfeng Wang, Li Qin, Biqing Zhao, Liang Cai, Zhenping Zhong, Yonghong Liu, et\u00a0al, Two rare tigliane diterpenoid derivatives against K562 cells from Croton tiglium, Org Biomol Chem. DOI: 10.1039\/c8ob02519c.","DOI":"10.1039\/C8OB02519C"},{"key":"10.1016\/j.jaim.2022.100545_bib153","series-title":"A\u00a0brief history of the wondrous oleander plant-Part 3 of the oleander series","year":"2013"},{"key":"10.1016\/j.jaim.2022.100545_bib154","series-title":"Nerium Biotechnology, Inc.","year":"2013"},{"key":"10.1016\/j.jaim.2022.100545_bib155","first-page":"444","article-title":"Susruta-Samhita; Volume II Chapter XVII, Verse 37-42","author":"Sharma","year":"2010"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib156","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3923\/ijbc.2010.190.202","article-title":"Screening of chemical analysis, antioxident antimicrobial and antitumor activity of essential oil of oleander (Nerium oleander) flower","volume":"4","author":"Ali","year":"2010","journal-title":"Int J Biol Chem"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib157","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0006-2952(01)00690-6","article-title":"Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin","volume":"62","author":"Smith","year":"2001","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.jaim.2022.100545_bib158","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.taap.2003.09.027","article-title":"Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion markers in CD-1 mouse skin by oleandrin","volume":"195","author":"Afaq","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1016\/j.jaim.2022.100545_bib159","first-page":"167","article-title":"Oleandrin-mediated oxidative stress in human melanoma cells","volume":"5","author":"Newman","year":"2006","journal-title":"J\u00a0Exp Therapeut Oncol"},{"issue":"SUPP","key":"10.1016\/j.jaim.2022.100545_bib160","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1016\/j.clim.2006.04.509","article-title":"Nerium oleander leaf extract sensitizes human burkett cell lymphoma (Raji) to human cytotoxicity mediated by natural killer cells","volume":"119","author":"Ghoneum","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaim.2022.100545_bib161","first-page":"31","article-title":"Cytotoxic effects of leaf, stem and root extracts of Nerium oleander on leukemia cell lines and role of the p-glycoprotein in this effect","volume":"6","author":"Turan","year":"2006","journal-title":"J\u00a0Exp Therapeut Oncol"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib162","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/1534735407309623","article-title":"Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside","volume":"6","author":"Newman","year":"2007","journal-title":"Integr Cancer Ther"},{"issue":"8 Suppl","key":"10.1016\/j.jaim.2022.100545_bib163","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/1538-7445.AM2013-5572","article-title":"Breastin a natural product from Nerium Oleander exhibits high activity in a panel of human tumor cell lines","volume":"73","author":"Fiebig","year":"2013","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib164","first-page":"7","article-title":"Antioxidant activity and anticancer study on phytochemicals extract from tubers of Gloriosa superba against human cancer cell (Hep-G2)","volume":"4","author":"Simon","year":"2016","journal-title":"Res Rev: J Pharmacogn Phytochem"},{"key":"10.1016\/j.jaim.2022.100545_bib165","series-title":"Extracts, compositions and use thereof, International Application Published Under The Patent Cooperation Treaty (PCT), WO 2016\/146562 Al","author":"Luc","year":"2016"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib166","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/14756360601164853","article-title":"Enzyme inhibition activities of the extracts from rhizomes of Gloriosa superba Linn (Colchicaceae)","volume":"22","author":"Khan","year":"2007","journal-title":"J\u00a0Enzym Inhib Med Chem"},{"key":"10.1016\/j.jaim.2022.100545_bib167","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00044-012-0032-z","article-title":"Bioactive metabolites from an endophytic fungus of Aspergillus species isolated from seeds of Gloriosa superba Linn","volume":"22","author":"Budhiraja","year":"2013","journal-title":"Med Chem Res"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib168","first-page":"27","article-title":"Phytochemical and pharmacological evaluation of Gloriosa superba","volume":"5","author":"Shah","year":"2015","journal-title":"J\u00a0Drug Deliv Therapeut"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib169","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjms.2017.06.005","article-title":"Partially purified Gloriosa superba peptides inhibit colon cancer cell viability by inducing apoptosis through p53 upregulation","volume":"354","author":"Budchart","year":"2017","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.jaim.2022.100545_bib170","first-page":"1769","article-title":"Characteristic and optimized use of bioactive compounds from Gloriosa superba and albizia amara with apoptotic effect on hepatic and squamous skin carcinoma","volume":"9","author":"Jayakumar","year":"2018","journal-title":"Int J Pharmaceut Sci Res"},{"key":"10.1016\/j.jaim.2022.100545_bib171","first-page":"58","volume":"vol. 508","author":"Srikanth Murthy","year":"2012"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib172","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/np010073b","article-title":"Lignanamides and nonalkaloidal components of Hyoscyamus Niger seeds","volume":"65","author":"Ma","year":"2002","journal-title":"J\u00a0Nat Prod"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib173","first-page":"50","article-title":"In\u00a0vitro anti-bacterial and anti tumor efficiency of some traditional plants from Turkey","volume":"17","author":"Turker","year":"2018","journal-title":"Indian J Tradit Knowledge"},{"key":"10.1016\/j.jaim.2022.100545_bib174","series-title":"Cytogenetic and cytotoxic studies on the effect of phytoinvestigated active compounds of Hyoscyamus Niger (in\u00a0vivo and ex\u00a0vivo)","author":"Ismeel","year":"2011"},{"issue":"3","key":"10.1016\/j.jaim.2022.100545_bib175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4274\/tjps.80299","article-title":"Cytotoxic activities of certain medicinal plants on different cancer cell lines","volume":"14","author":"Deniz","year":"2017","journal-title":"Turk J Pharm Sci"},{"key":"10.1016\/j.jaim.2022.100545_bib176","series-title":"Classical uses of medicinal plants","first-page":"397","author":"Sharma","year":"2004"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib177","first-page":"521","article-title":"Radioprotective and in-vitro cytotoxic sapogenin from Euphorbia neriifolia (Euphorbiaceae) leaf","volume":"8","author":"Bigoniya","year":"2009","journal-title":"Trop J Pharmaceut Res"},{"key":"10.1016\/j.jaim.2022.100545_bib178","unstructured":"Patil S B and Magdum C S, Determination of LC50 values of extracts of Euphorbia hirta Linn and Euphorbia neriifolia Linn using brine shrimp lethality assay, Asian J Res Pharm Sci 1(2): April-June 2011; Page 42-43."},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib179","first-page":"5","article-title":"A\u00a0study on anti-cancer activity of Euphorbia neriifolia (milk hedge) latex","volume":"5","author":"Upadhyaya","year":"2017","journal-title":"Int J Adv Sci Eng Technol"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib180","first-page":"36","article-title":"Chemoprotective activity of hydro-ethanolic extract of Euphorbia neriifolia Linn leaves against DENA-induced liver carcinogenesis in mice","volume":"3","author":"Pracheta","year":"2011","journal-title":"Biol Med"},{"key":"10.1016\/j.jaim.2022.100545_bib181","unstructured":"Janmeda P, Sharma V, Singh L, Paliwal R, Sharma S, Yadav S, et\u00a0al, Chemopreventive effect of hydroethanolic extract of Euphorbia neriifolia leaves against DENA-induced renal carcinogenesis in mice, Asian Pac J Cancer Prev APJCP, 12, 677-683."},{"key":"10.1016\/j.jaim.2022.100545_bib182","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201900495","article-title":"Diterpenoids from Euphorbia neriifolia and their related anti-HIV and cytotoxic activity","volume":"16","author":"Li","year":"2019","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.jaim.2022.100545_bib183","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/978-3-642-22144-6_191","article-title":"Aconitum alkaloids and biological activities","author":"Chodoeva","year":"2013","journal-title":"Natural Products"},{"issue":"6","key":"10.1016\/j.jaim.2022.100545_bib184","first-page":"427","article-title":"Hypaconitine inhibits TGF-\u03b21-induced epithelial\u2013mesenchymal transition and suppresses adhesion, migration, and invasion of lung cancer A549 cells","volume":"15","author":"Feng","year":"2017","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.jaim.2022.100545_bib185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2012.05.015","article-title":"Hemisynthesis and antiproliferative properties of mono-[O-(14-benzoylaconine-8-yl)]esters and bis-[O-(14-benzoylaconine-8-yl)]esters","volume":"54","author":"Chodoeva","year":"2012","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib186","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10637-013-9986-z","article-title":"Antitumor activity of semisynthetic derivatives of Aconitum alkaloids","volume":"32","author":"Chodoeva","year":"2014","journal-title":"Invest N Drugs"},{"key":"10.1016\/j.jaim.2022.100545_bib187","series-title":"Chinese herbal medicine","first-page":"646","author":"Bensky","year":"1986"},{"key":"10.1016\/j.jaim.2022.100545_bib188","first-page":"425","article-title":"Cytotoxicities of alkaloids from processed and unprocessed seeds of Strychnos nux-vomica","volume":"19","author":"Cai","year":"1998","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jaim.2022.100545_bib189","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/toxsci\/kfj114","article-title":"The apoptotic effect of brucine from the seed of Strychnos nux-vomica on human hepatoma cells is mediated via Bcl-2 and Ca2+ involved mitochondrial pathway","volume":"91","author":"Deng","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaim.2022.100545_bib190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.fct.2008.10.027","article-title":"Anti-proliferative and cytotoxic effects of Strychnos nux-vomica root extract on human multiple myeloma cell line-RPMI 8226","volume":"47","author":"Rao","year":"2009","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaim.2022.100545_bib191","article-title":"Anticancer effects of brucine and gemcitabine combination in MCF-7 human breast cancer cells","author":"Serasanambati","year":"2014","journal-title":"Nat Prod Res: Formerly Nat Prod Lett"},{"key":"10.1016\/j.jaim.2022.100545_bib192","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s00044-011-9832-9","article-title":"A\u00a0cytotoxic agent from Strychnos nux-vomica and biological evaluation of its modified analogues","volume":"21","author":"Khan","year":"2012","journal-title":"Med Chem Res"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib193","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.fct.2008.10.027","article-title":"Anti-proliferative effects of Syrychnos nux-vomica root extract on human multiple myeloma cell line- RPMI 8226","volume":"47","author":"Rao","year":"2009","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaim.2022.100545_bib194","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10616-014-9723-2","article-title":"Phytochemical study, cytotoxic, analgesic, antipyretic and anti-inflammatory activities of Strychnos nux-vomica","volume":"67","author":"Eldahshan","year":"2015","journal-title":"Cytotechnology"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/2231-4040.72270","article-title":"In\u00a0vitro cytotoxicity study of Agave americana, Strychnos nuxvomica and Areca catechu extracts using MCF-7 cell line","volume":"1","author":"Anajwala","year":"2010","journal-title":"J\u00a0Adv Pharm Technol Res (JAPTR)"},{"key":"10.1016\/j.jaim.2022.100545_bib196","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.fct.2013.05.011","article-title":"Brucine, an effective natural compound derived from nux-vomica, induces G1 phase arrest and apoptosis in LoVo cells","volume":"58","author":"Zheng","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaim.2022.100545_bib197","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12013-012-9492-5","article-title":"Strychnos nux-vomica root extract induces apoptosis in the human multiple myeloma cell line\u2014U266B1","volume":"66","author":"Rao","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.jaim.2022.100545_bib198","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.lfs.2011.05.020","article-title":"Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line","volume":"89","author":"Agrawal","year":"2011","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib199","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2013.01.012","article-title":"Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in\u00a0vitro and in\u00a0vivo","volume":"332","author":"Saraswati","year":"2013","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxlet.2013.07.024","article-title":"An alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway","volume":"222","author":"Shu","year":"2013","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jaim.2022.100545_bib201","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cbi.2013.09.012","article-title":"Anticarcinogenic effect of brucine in diethylnitrosamine initiated and phenobarbital-promoted hepatocarcinogenesis in rats","volume":"206","author":"Saraswati","year":"2013","journal-title":"Chem Biol Interact"},{"issue":"2","key":"10.1016\/j.jaim.2022.100545_bib202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jep.2005.12.021","article-title":"The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism","volume":"106","author":"Deng","year":"2006","journal-title":"J\u00a0Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.jaim.2022.100545_bib203","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11655-017-2805-1","article-title":"Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions","volume":"24","author":"Li","year":"2018","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.jaim.2022.100545_bib204","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.2147\/IJN.S136378","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of novel NGR-modified liposomes containing brucine","volume":"12","author":"Li","year":"2017","journal-title":"Int J Nanomed"},{"issue":"11","key":"10.1016\/j.jaim.2022.100545_bib205","first-page":"989","article-title":"Biological and pharmacological properties of Aconitum chasmanthum","volume":"3","author":"Anwar","year":"2003","journal-title":"J\u00a0Biol Sci"},{"issue":"4","key":"10.1016\/j.jaim.2022.100545_bib206","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/0257-7941.160862","article-title":"\u015aodhana: an Ayurvedic process for detoxification and modification of therapeutic activities of poisonous medicinal plants","volume":"34","author":"Maurya","year":"2015","journal-title":"Ancient Sci Life"},{"key":"10.1016\/j.jaim.2022.100545_bib207","article-title":"Guidelines on the prevention of toxic exposures education and public awareness activities international programme on chemical safety UNEP","volume":"1\u2013116","author":"WHO","year":"2004","journal-title":"Int Program Chem Saf"},{"key":"10.1016\/j.jaim.2022.100545_bib208","series-title":"Guidelines series-I general Guidelines for drug development of ayurvedic formulations","author":"Series-i","year":"2018"},{"key":"10.1016\/j.jaim.2022.100545_bib209","first-page":"514","article-title":"Current issues regarding Complementary and Alternative Medicine (cam) in the United States - Part 2: regulatory and safety concerns and proposed governmental policy changes with respect to dietary supplements","volume":"35","author":"Ventola","year":"2010","journal-title":"P\u00a0T"},{"key":"10.1016\/j.jaim.2022.100545_bib210","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.26452\/ijrps.v10i4.1609","article-title":"Regulatory compliance of herbal medicines \u2013 a review","volume":"10","author":"Ramadoss","year":"2019","journal-title":"Int J Res Pharm Sci"},{"key":"10.1016\/j.jaim.2022.100545_bib212","series-title":"Drugs approved for different types of cancer","author":"Institute","year":"2021"},{"key":"10.1016\/j.jaim.2022.100545_bib213","unstructured":"Institute NC. Topotecan hydrochloride n.d. https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/topotecanhydrochloride."},{"key":"10.1016\/j.jaim.2022.100545_bib214","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.3390\/ijms19123950","article-title":"Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy","volume":"19","author":"Garc\u00eda-Aranda","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaim.2022.100545_bib215","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.bmcl.2018.06.044","article-title":"Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead","volume":"28","author":"Martino","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jaim.2022.100545_bib216","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1038\/onc.2008.297","article-title":"Caspases in apoptosis and beyond","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.jaim.2022.100545_bib217","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/107555302320825129","article-title":"An assessment of the ayurvedic concept of cancer and a new paradigm of anticancer treatment in Ayurveda","volume":"8","author":"Singh","year":"2002","journal-title":"J\u00a0Alternative Compl Med"},{"issue":"9\u201310","key":"10.1016\/j.jaim.2022.100545_bib218","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/acm.2018.0161","article-title":"Ayurveda in cancer care in India: scope, challenges, and suggested approaches","volume":"24","author":"Gundeti","year":"2018","journal-title":"J\u00a0Alternative Compl Med"}],"container-title":["Journal of Ayurveda and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0975947622000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0975947622000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:17:38Z","timestamp":1760854658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0975947622000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":217,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0975947622000043"],"URL":"https:\/\/doi.org\/10.1016\/j.jaim.2022.100545","relation":{},"ISSN":["0975-9476"],"issn-type":[{"value":"0975-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations","name":"articletitle","label":"Article Title"},{"value":"Journal of Ayurveda and Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaim.2022.100545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of Institute of Transdisciplinary Health Sciences and Technology and World Ayurveda Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100545"}}